The effect of cyclooxygenase-2 inhibitor FK3311 on ischemia-reperfusion injury in a canine total hepatic vascular exclusion model

Journal of the American College of Surgeons

Volumn 192, Issue 1, 2001, Pages 54-62

  Sunose, Yutaka ^a   Takeyoshi, Izumi ^a   Ohwada, Susumu ^a   Tsutsumi, Hirofumi ^a   Iwazaki, Shigeru ^a   Kawata, Kiyoshi ^a   Kawashima, Yoshiyuki ^a   Tomizawa, Naoki ^a   Matsumoto, Koshi ^b   Morishita, Yasuo ^a  

^a GUNMA UNIVERSITY   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4' ACETYL 2' (2,4 DIFLUOROPHENOXY)METHANESULFONANILIDE; 6 OXOPROSTAGLANDIN F1 ALPHA; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYCLOOXYGENASE 2 INHIBITOR; HYALURONIC ACID; LACTATE DEHYDROGENASE; THROMBOXANE A2; THROMBOXANE B2;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DOG; DRUG EFFECT; DRUG INHIBITION; HEART MUSCLE ISCHEMIA; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER BLOOD FLOW; LIVER SURGERY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

6-KETOPROSTAGLANDIN F1 ALPHA; ALANINE TRANSAMINASE; ANALYSIS OF VARIANCE; ANILIDES; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; DOGS; ENZYME INHIBITORS; HYALURONIC ACID; ISOENZYMES; L-LACTATE DEHYDROGENASE; LEUKOCYTE COUNT; LIVER; LIVER CIRCULATION; NEUTROPHILS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RANDOM ALLOCATION; REPERFUSION INJURY; THROMBOXANE B2;

EID: 0035148561     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(00)00773-0     Document Type: Article

References (62)

1. Experience with liver and kidney allografts from non-heart-beating donors
2. Controlled non-heart-beating donors: A potential source of extrarenal organs
3. The use of non-heart-beating cadaver donors in experimental liver transplantation
4. Hepatic protein synthesis rate of liver specimens as a predictor of viability in rat cold ischemia liver transplantation model
5. Mitochondrial glutathione redox and energy producing function during liver ischemia and reperfusion
6. Prolonged hepatic warm ischemia in non-heart-beating donors: Protective effects of FK506 and a platelet activating factor antagonist in porcine liver transplantation
7. The effect of hypothermic perfusion with oxygenated perfluorochemical during in situ extended hepatectomy of canine liver
8. Inhibition of cyclooxygenase metabolite production attenuates ischemia-reperfusion lung injury
9. Role and regulation of cyclooxygenase-2 during inflammation
10. Studies on anti-inflammatory agents. III. Synthesis and pharmacological properties of metabolites of 4′-acetyl-2′-(2,4-difluorophenoxy) methanesulfonanilide (FK3311)
11. Rapid assay of hyaluronic acid in serum
12. Distribution of cyclooxygenase products with cyclooxygenase inhibition in isolated dog lung
13. 1
14. Risk factors for primary dysfunction after liver transplantation - A multivariate analysis
15. Preservation and reperfusion injuries in liver allografts: An overview and synthesis of current studies
16. Hepatic allograft procurement from non-heart-beating donors
17. Normothermic hepatic vascular exclusion for extensive hepatectomy
18. Technique of hepatic vascular exclusion for extensive liver resection
19. Vascular occlusion for liver resection
20. An experimental study of survival after two hours of normothermic hepatic ischemia
21. Major hepatic resection under total vascular exclusion
22. Energy charge as an indication of liver viability: A comparison of changes in livers that remained intact with those subjected to autografting
23. Inhibition of constitutive and inducible cyclooxygenase activity in human platelets and mononuclear cells by NSAIDs and Cox 2 inhibitors
24. 2, cyclooxygenase and terminal prostanoid synthases in different phases of prostanoid biosynthesis in rat peritoneal macrophages
25. Thromboxane contributes to pulmonary hypertension in ischemia-reperfusion lung injury
26. Studies on anti-inflammatory agents. I. Synthesis and pharmacological properties of 2′-phenoxy-methanesulfonanilide derivatives
27. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
28. 2 synthetase inhibitor on postischemic liver injury in rats
29. Effect of prostacyclin analogue OP-41483 and perfusate on liver preservation by simple hypothermia in rats
30. Pulmonary thromboxane release following intestinal reperfusion
31. Lasting beneficial effect of short-term inhaled nitric oxide on graft function after lung transplantation
32. Hepatic blood flow and oxygen extraction ratio during normothermic recirculation and total body cooling as viability predictors in non-heart-beating donor pigs
33. Effect of cyclooxygenase inhibition in a canine model of unilateral pulmonary occlusion and reperfusion
34. Antithrombin reduces ischemia/reperfusion injury of rat liver by increasing the hepatic level of prostacyclin
35. cAMP-mediated vascular protection in an orthotopic rat lung transplant model
36. 1 during the initial period of reperfusion
37. 2 analogue and prostacyclin on lung fluid balance in newborn lambs
38. Relative importance of prostaglandin/cyclic adenosine monophosphate and nitric oxide/cyclic guanosine monophosphate pathways in lung preservation
39. Low-dose nitric oxide inhalation during initial reperfusion enhances rat lung graft function
40. Rapid increase in the activity of enzymes of eicosanoid synthesis in hepatic and extrahepatic tissues after experimental liver transplantation
41. Effect of calcium antagonists on rat liver during extended cold preservation-reperfusion
42. Reperfusion damage to the bile canaliculi in transplanted human liver
43. Bile flow - An index of ischemic injury
44. Role of glutathione in hepatic bile formation during reperfusion after cold ischemia of the rat liver
45. The greater vulnerability of bile duct cells to reoxygenation injury than to anoxia. Implications for the pathogenesis of biliary strictures after liver transplantation
46. Ischemic-type biliary complications after orthotopic liver transplantation
47. The effect of FK 409 - A nitric oxide donor - On canine lung transplantation
48. Prevention of ischemia reperfusion lung injury by inhaled nitric oxide in neonatal piglets
49. Methylene blue potentiates vascular reactivity in isolated rat lungs
50. Interleukin 1 and tumor necrosis factor production as the initial stimulants of liver ischemia and reperfusion injury
51. Superoxide generation by Kupffer cells and priming of neutrophils during reperfusion after hepatic ischemia
52. Extended ex vivo preservation of the heart and lungs. Effects of acellular oxygen-carrying perfusates and indomethacin on the autoperfused working heart-lung preparation
53. 2 analogue, on reperfusion injury to rabbit lungs
54. 2 moderate postischemic renal failure
55. Vasodilating prostaglandins attenuate ischemic renal injury only if thromboxane is inhibited
56. Edema from cyclooxygenase products of endogenous arachidonic acid in isolated lung
57. 2 synthetase inhibitor against ischemic liver injury
58. Effect of thromboxane synthetase inhibitor on non-heart-beating donors in rat orthotopic liver transplantation
59. Prostacyclin analogue (OP-2507) attenuates hepatic microcirculatory derangement, energy depletion, and lipid peroxidation in a rat model of reperfusion injury
60. Differential inhibition of human prostaglandin endoperoxide synthase-1 and -2 by nonsteroidal anti-inflammatory drugs
61. Limited anti-inflammatory efficacy of cyclooxygenase-2 inhibition in carrageenan-airpouch inflammation
62. 2 activity, and lipid peroxidation in pancreas transplantation